Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy of ManNAc in Subjects With GNE Myopathy

NCT04231266 is registered in ClinicalTrials.gov with Leadiant Biosciences, Inc. as lead sponsor.

NCT NCT04231266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04231266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy of ManNAc in Subjects With GNE Myopathy
Lead sponsor
Leadiant Biosciences, Inc.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
April 5, 2022
Completion date
October 30, 2025
Enrollment
54 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

gne myopathy